News for Multi-Modal Cancer Therapies

On 14th March 2012 the NIHR Biomedical Research Centre and the Oxford Cancer Research Centre (right) hosted a public open day on research that is designed to improve health.  A morning session was held for secondary schools, introducing them to the world of cancer research.  Scientists, doctors, nurses and technicians were on hand to demonstrate the latest … Read more

Doctors, surgeons and researchers from the Imaging Theme of the NIHR Biomedical Research Centre, Oxford are looking into the effectiveness of using ablation as another treatment option for lung, liver and renal tumours. Microwave Ablation is used to treat small tumors by passing a needle-like probe inside the tumour. The microwaves released from the probe increase the temperature within tumour tissue that … Read more

A CANCER RESEARCH UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. The trial, led by a team based at the National Institute for Health Research (NIHR) Oxford Biomedical Research … Read more

While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another. A team of researchers from The Cancer Institute of New Jersey (CINJ) and Princeton University, along … Read more

Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this cancer. Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder that causes the development of benign but often painful tumours … Read more

Last December, Kevin Jones, a 43-year-old businessman from Dorset was diagnosed with pancreatic cancer. It was advanced and inoperable. Today, as he prepares to celebrate Christmas with his son, Mr Jones is free from any detectable trace of the disease; the human face of a medical breakthrough so exciting that the scientists involved struggle to … Read more

Taking a low-dose aspirin every day will reduce your chances of dying from cancer, scientists say today, confirming the over-the-counter pill as the most extraordinary drug yet discovered. Daily aspirin has already been shown to cut the chances of heart attacks and stroke in people who are at risk. The study published today in the … Read more

Professor Peter Rothwell, of the John Radcliffe Hospital, Oxford, and Oxford University, describes the findings of a recent study, tipping the balance in favour of regular aspirin use. http://www.bbc.co.uk/news/health-11597163 http://www.guardian.co.uk/society/2010/oct/22/aspirin-reduce-bowel-cancer-risk

Researchers at Immunocore Limited today announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrolment for clinical trials in the England and USA. IMCgp100 is the first clinical candidate originating from Immunocore’s innovative ImmTAC technology platform and a new treatment could benefit … Read more

Professor Mark Middleton, Professor John Bell, Dr Jenny Taylor and research colleagues from Oxford were interviewed on BBC Radio 4 on 17 February about new generations of cancer drugs. Discussions centred around advances in tumour mapping, patients’ experiences, advances in genetic testing and research funded by the NIHR Biomedical Research Centre, Oxford. To listen again visit http://www.bbc.co.uk/programmes/b006qps9 (interview … Read more